This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Ellis-van Creveld Syndrome (Chondroectodermal Dysplasia)엘리스-반크레벨트증후군 (Ellis-van Creveld증후군)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q77.6 (Ellis-van Creveld syndrome) | Special Copayment Reduction: V228 (rare disease)
B. SynonymsEllis-van Creveld syndrome, chondroectodermal dysplasia, EVC syndrome
C. Adult onsetLikelihood of first presentation in adulthood very low — diagnosed at birth or prenatally; congenital heart malformation is the main determinant of prognosis.
1. History1940: first description by Ellis and van Creveld → 1964: McKusick reported the Amish founder effect → 2000: EVC gene identified → 2003: EVC2 (LIMBIN) discovered.
2. CausesBiallelic variants in the EVC or EVC2 gene. Autosomal recessive. Dysfunction of the ciliary complex of the hedgehog (Hh) signaling pathway. Amish founder variant (EVC).
3. GeneticsEVC: 4p16, EVC2: 4p16 (adjacent). Autosomal recessive. The two genes are arranged in opposite orientations and share regulatory elements. Included in the group of diseases related to ciliary dysfunction (ciliopathies).
4. General epidemiology1 in 60,000–200,000 births. About 1/5,000 among the Amish. At least several hundred worldwide. No sex predilection.
5. PathophysiologyEVC/EVC2 proteins form a complex at the ciliary base → regulate Smo activation → abnormal regulation of GLI transcription factor activity → impaired cartilage, ectoderm and heart development.
6. SymptomsShort-limbed dwarfism, polydactyly (especially of the hands), nail hypoplasia, dental abnormalities (natal teeth, dysplastic teeth), congenital heart malformation (single atrium 60%), narrow thorax.
7. SignsDistal-type limb shortening, bilateral polydactyly (sixth finger), lip frenula, heart murmur (congenital heart malformation), radiographic distal limb and pelvic abnormalities.
8. ScreeningPrenatal ultrasound (limb shortening, polydactyly, cardiac abnormalities, narrow thorax). Prenatal molecular genetic testing for EVC/EVC2 in high-risk families. Fetal echocardiography.
9. DiagnosisClinical tetrad (short limbs + polydactyly + ectodermal abnormalities + congenital heart malformation) + molecular genetic confirmation of EVC/EVC2. Echocardiography, full skeletal radiography.
10. TreatmentSurgery for congenital heart malformation (correction of single atrium). Surgical excision of polydactyly. Dental treatment (correction of dental abnormalities). Respiratory support. Multidisciplinary management.
11. PrognosisLife expectancy nearly normal after treatment of the heart malformation. High infant mortality if the heart malformation is untreated. Normal intelligence. Adult height 110–150cm.
12. PreventionGenetic counseling, PGT, prenatal EVC/EVC2 analysis. Prenatal fetal echocardiography. Early surgical correction of congenital heart malformation.
13. ReferencesEllis RWB, van Creveld S. Arch Dis Child 1940; Ruiz-Perez VL et al. Nat Genet 2000; Ruiz-Perez VL et al. Hum Mol Genet 2003 … and 7 others

1. History

Ellis-van Creveld syndrome (EvC) is a disease with a very interesting historical background: in 1940, the British pediatrician Richard W.B. Ellis and the Dutch pediatrician Simon van Creveld, each having independently seen similar patients, happened to meet in the same train compartment, compared and discussed their cases, and then described them jointly. The two physicians recognized that patients showing the combination of short-limbed dwarfism, polydactyly, nail hypoplasia, oral malformations and congenital heart malformations constituted an independent disease, and published a joint paper in Archives of Disease in Childhood in 1940. The syndrome was subsequently named 'Ellis-van Creveld syndrome' after the two physicians, and because it involves both the skeletal system and ectodermal tissues, the descriptive name 'chondroectodermal dysplasia' is also used.

In 1964, the American physician Victor McKusick and colleagues reported a markedly high frequency of EvC in the Amish community of Pennsylvania. The Amish community is a closed population derived from a small founder group in the 18th century, in which the founder effect is prominent: specific gene variants derived from a few founder individuals are maintained at high frequency over generations. McKusick and colleagues' Amish study established the autosomal recessive inheritance of EvC and was subsequently cited as a textbook example illustrating the principles of genetic epidemiology.

The causative gene was identified in 2000, when Víctor L. Ruiz-Pérez et al. identified the EVC gene on chromosome 4p16. Three years later, in 2003, the same research group discovered the EVC2 (LIMBIN) gene, located adjacent to EVC in the opposite orientation. It was shown that the two genes are arranged at 4p16 as a head-to-head gene pair and share regulatory elements. Subsequent studies established that the EVC and EVC2 proteins localize to a superstructure at the base of cilia and regulate the Hedgehog (Hh) signaling pathway, and EvC came to be classified as a ciliopathy.


2. Causes

Ellis-van Creveld syndrome is an autosomal recessive genetic disorder caused by biallelic pathogenic variants in the EVC or EVC2 gene, located on the short arm of chromosome 4 (4p16). The two genes are arranged head-to-head, separated by a short distance of about 3 kb, and are regulated through shared promoter elements.

The EVC gene consists of 21 exons and encodes a 1,005-amino-acid protein. The EVC2 gene consists of 22 exons and encodes a 1,978-amino-acid protein (LIMBIN). The two proteins form the EVC-EVC2 complex at the ciliary base and regulate activation of Smoothened (Smo), a key component of the Hedgehog signaling pathway, and signal transduction to the GLI transcription factors.

In the Amish community, a single founder variant of the EVC gene (c.1621_1622del, p.S541fs or c.2816_2817del, etc.) is maintained at high frequency. In non-Amish populations, diverse variants (nonsense, frameshift, splicing, missense) have been reported in both EVC and EVC2. EVC variants and EVC2 variants cause the same, clinically indistinguishable phenotype. In some patients, large deletions involving both genes are found. Compound heterozygous variants (a different variant on each allele) are common.

EvC has recently been classified as a member of the ciliopathies. Cilia are microscopic structures projecting from the cell surface and serve as a key platform for various developmental signaling pathways, including Hedgehog signaling. Defects in the EVC/EVC2 protein complex cause abnormal Hh signal transduction in cilia, impairing the development of various organs, including cartilage, ectodermal tissues (nails, teeth, hair), and the heart.


3. Genetics

The EVC and EVC2 genes are arranged head-to-head in opposite orientations on the short arm of chromosome 4 (4p16), about 3 kb apart. Because of this unusual gene arrangement, the 5' promoter regions of the two genes are shared, and expression of both genes is coordinated by the same regulatory elements. The mode of inheritance is autosomal recessive. Carrier (heterozygous) parents are asymptomatic, and 25% of children of carrier couples are affected.

The EVC and EVC2 proteins form the "EVC-EVC2 complex (EvC zone)" at the ciliary base and regulate the localization and activity of activated Smoothened (Smo) within the cilium. When a Hedgehog (Hh) ligand (Sonic hedgehog, SHH, etc.) binds the receptor Patched (Ptch1), Ptch1's inhibition of Smo is released, and Smo moves into the cilium and is activated, converting the GLI transcription factors (GLI2, GLI3) to their active forms. When the EVC/EVC2 complex is dysfunctional, this Smo activation step is disrupted and Hh signal transduction is reduced, impairing Hh-dependent developmental processes such as the cartilage growth plate, ectodermal organ primordia, and cardiac septum formation.

Genotype-phenotype correlations have not been clearly established. EVC variants and EVC2 variants cause clinically identical phenotypes, and differences in clinical severity by variant type (nonsense vs missense) and location are difficult to predict because of large interindividual variability. In particular, the occurrence and severity of congenital heart defects vary independently of genotype. Therefore, molecular genetic confirmation plays a more important role in confirming the diagnosis and in family counseling than in predicting prognosis.

EvC shares molecular mechanistic links with other ciliopathies—Bardet-Biedl syndrome, Joubert syndrome, Meckel-Gruber syndrome, Jeune asphyxiating thoracic dysplasia, etc.—and some clinical findings (polydactyly, organ inversion, etc.) may overlap. Multigene ciliopathy panel NGS testing is helpful for differential diagnosis.


4. General epidemiology

The worldwide incidence of Ellis-van Creveld syndrome is 1 in 60,000~200,000 births, making it a very rare disease. The number of patients worldwide is estimated at several hundred to several thousand, and accurate registry data are limited. There is no difference in incidence between males and females; as an autosomal recessive disorder, it is not influenced by sex.

Marked regional differences in incidence are observed. In the Amish community of Pennsylvania, USA, the incidence is about 1/5,000, markedly higher than in the general population; this is due to a founder effect, in which EVC variant carriers were included in an 18th-century founder population, so that the carrier frequency has remained high at about 1/8~1/13 in the descendant population. Increased EvC incidence due to similar founder effects has also been reported in several other small, closed populations.

In East Asia, including Korea, the incidence is similar to or lower than that of the Western general population, making it a very rare disease. In Korea, very few patients are registered for Special Copayment Reduction (V228), and individual cases are reported in the literature as rare case reports. Diagnostic rates are improving with the spread of prenatal ultrasound screening and molecular genetic testing, but diagnostic delay may occur with atypical clinical findings or in mild cases without congenital heart defects.


5. Pathophysiology

The core pathophysiology of Ellis-van Creveld syndrome is abnormal Hedgehog (Hh) signal transduction in cilia. In normal development, Hh signaling is a key pathway regulating chondrocyte proliferation and differentiation in the cartilage growth plate, development of ectodermal organs (nails, teeth, sweat glands), cardiac septum formation, and limb development (especially ulnar/distal patterning).

The EVC and EVC2 proteins form a unique complex (EVC-EVC2 supercomplex) near the transition zone at the base of primary cilia. This complex promotes the process by which Smoothened (Smo) enters the cilium and is activated after a Hedgehog ligand (SHH, IHH, etc.) binds Patched (PTCH1). When EVC/EVC2 function is lost, ciliary activation of Smo is reduced and the downstream GLI transcription factors remain in the repressor form (GLI3R), lowering expression of Hh target genes.

In limb development, Hh signaling (especially IHH, Indian Hedgehog) promotes chondrocyte proliferation in the cartilage growth plate, and Sonic hedgehog (SHH) is involved in suppressing polydactyly through distal/ulnar limb patterning (zone of polarizing activity, ZPA). Reduced SHH/IHH signaling due to EVC/EVC2 defects simultaneously explains distal limb growth impairment (acromelic dwarfism) and ulnar polydactyly (a sixth finger).

In cardiac development, Hh signaling is involved in endocardial cushion formation and atrial septal development. With EVC defects, atrial and atrioventricular septal formation is incomplete, resulting in single atrium/common atrium, the most characteristic congenital heart defect of EvC. In ectodermal organ development, Hh signaling (SHH) regulates the development of dental enamel, nails, and sweat glands, and with EVC defects, abnormal formation of these ectoderm-derived structures occurs.

The development of polydactyly is related to a decrease in the GLI3 repressor form (GLI3R). Normally GLI3R plays an important role in suppressing the ulnar (posterior) side of the digits; when Hh signaling is reduced, GLI3R may paradoxically also decrease (because Hh prevents conversion of GLI3 to its repressor form), resulting in complex regulation, which explains the complex mechanism by which polydactyly occurs in ciliopathies.


6. Symptoms

The clinical symptoms of Ellis-van Creveld syndrome are broadly divided into four areas—skeletal, ectodermal, congenital heart defects, and other.

Skeletal symptoms: Dwarfism with acromesomelic limb shortening is characteristic. Adult height is in the range of 110~150cm, less severe than in achondroplasia. The distal (hands, feet) and middle (forearms, lower legs) segments are shortened more than the proximal segments (acromelic + mesomelic). Polydactyly of both hands occurs in almost all patients, with a sixth finger added on the ulnar side of the little finger. Polydactyly may also occur in the feet. The chest is narrow and the ribs are short, which may cause respiratory restriction in infancy.

Ectodermal symptoms (ectodermal dysplasia): Nail hypoplasia is characteristic, and the nails may be small, deformed, or absent. Dental abnormalities are very prominent, with natal teeth (teeth already erupted at birth), malformed teeth, missing teeth, and a granular tooth surface. Abnormal multiple oral frenula (labial frenula) are characteristic, and multiple frenula connecting the lip (upper lip) to the alveolar ridge are an almost specific finding of EvC. Hair abnormalities are mild, and sweat gland dysfunction has also been reported.

Congenital heart defects: Congenital heart defects are present in about 50~60% of all patients and are the main cause of death in infancy. The most characteristic heart defect is common atrium (single atrium), in which the atrial septum is completely absent. In addition, various congenital heart defects may be present, including atrial septal defect (ASD), ventricular septal defect (VSD), atrioventricular septal defect (AVSD), and transposition of the great arteries.

Other symptoms: Some patients may have genitourinary abnormalities (renal malformations, hypospadias, hydrocele), ocular abnormalities (nystagmus, hyperopia), genu valgum, scoliosis, etc. Intellectual ability is normal.


7. Signs

Physical signs: At birth, short limbs, six fingers (bilateral), nail hypoplasia, multiple oral frenula (labial frenula), and natal teeth are clearly observed. On chest auscultation, a heart murmur due to a congenital heart defect (holosystolic murmur, atrioventricular septal defect) is heard. Cyanosis (reduced oxygen saturation) may occur with severe heart defects, accompanied by symptoms of heart failure in infancy (rapid breathing, poor feeding, poor weight gain).

Radiologic signs: Whole-body skeletal radiographs show short distal long bones, abnormal shape of the distal humerus/femur, ulnar polydactyly, hypoplasia of the distal ulna, and metatarsal fusion. Pelvic X-rays show abnormal iliac development and a horizontal acetabular roof. Chest radiographs show a narrow thorax and short horizontal ribs.

Echocardiographic findings: Single atrium, atrial septal defect, and atrioventricular septal defect are identified on echocardiography. Common atrium, with no atrial septum at all, is an almost specific finding of EvC and, unlike congenital heart defects from other causes, is characterized by complete absence of the atrial septum. Ventricular function and the presence of pulmonary hypertension are also evaluated.

Oral findings: Oral examination reveals multiple frenula between the upper lip and the alveolar ridge (multiple labial frenula). Natal teeth have insufficiently developed roots and, as loose teeth, carry a risk of aspiration, so removal is necessary. Abnormal tooth number, malformed teeth, and enamel hypoplasia are observed.


8. Screening

Population-wide screening of the general population for Ellis-van Creveld syndrome is not performed; screening is carried out in high-risk groups and when abnormal prenatal findings are present.

Prenatal ultrasound: EvC is suspected when short limbs, polydactyly of the hands (six fingers), a narrow thorax, and cardiac structural abnormalities (single atrium, atrioventricular septal defect) are observed on standard prenatal ultrasound. The combination of polydactyly and congenital heart defects strongly suggests a ciliopathy, including EvC. If these findings are identified on the standard detailed ultrasound at 20 weeks of gestation, immediate genetic analysis is recommended.

Fetal echocardiography: When a cardiac abnormality is suspected on prenatal ultrasound, fetal echocardiography is performed to evaluate the type and severity of the cardiac structural abnormality. Accurate structural assessment of the single atrium and atrioventricular septal defect is essential for planning surgery after birth.

Molecular genetic prenatal diagnosis: In pregnancies of carrier couples or when prenatal ultrasound abnormalities are present, fetal DNA is obtained by chorionic villus sampling or amniocentesis and analyzed for EVC and EVC2 gene variants. In those of Amish descent, known founder variants are analyzed first; in non-Amish patients, NGS-based analysis of both entire genes is required.

Preimplantation genetic testing (PGT): In carrier couples, a preventive approach is possible by using PGT to exclude affected embryos and implant unaffected embryos.


9. Diagnosis

The diagnosis of Ellis-van Creveld syndrome proceeds in steps: identifying the characteristic clinical tetrad (short-limbed dwarfism + polydactyly + ectodermal dysplasia + congenital heart defect) and confirming it by EVC/EVC2 molecular genetic analysis.

Clinical diagnostic criteria: ① acromelic dwarfism, ② bilateral ulnar polydactyly of the hands (a sixth finger), ③ ectodermal dysplasia (nail hypoplasia, dental abnormalities, multiple oral frenula), ④ congenital heart defect (single atrium, AVSD, ASD, VSD). If 3 or more of these 4 major findings are present, EvC is strongly suspected and is confirmed by molecular genetic testing.

Radiologic diagnosis: A skeletal survey confirms shortening of the distal long bones, polydactyly, and pelvic abnormalities (horizontal acetabulum). Chest X-ray evaluates a narrow thorax, cardiomegaly (due to a congenital heart defect), etc. Echocardiography defines the exact anatomy of the congenital heart defect, which is essential for preoperative planning.

Molecular genetic confirmation: NGS-based analysis of the EVC and EVC2 genes (single gene or skeletal dysplasia panel) identifies biallelic pathogenic variants. In those of Amish descent, known founder variants are analyzed first. Molecular genetic confirmation is the basis for family carrier testing, genetic counseling, and preimplantation and prenatal diagnosis.

Differential diagnosis: Jeune asphyxiating thoracic dystrophy — prominent narrow thorax without polydactyly, IFT genes. Bardet-Biedl syndrome — retinal dystrophy, obesity, intellectual disability, renal abnormalities. Pallister-Hall syndrome — hypothalamic hamartoma, GLI3 variants. McKusick-Kaufman syndrome — MKKS gene. All are cilia-related disorders that include polydactyly, but their clinical features and causative genes differ.


10. Treatment

There is no curative treatment for Ellis-van Creveld syndrome; treatment is a multidisciplinary approach focused on managing complications and correcting organ-specific abnormalities.

Surgery for congenital heart defects: Congenital heart defects are the most important factor determining the prognosis of EvC. Common atrium requires reconstruction of the atrial septum by open-heart surgery, and atrioventricular septal defect (AVSD) is also an indication for surgical correction. The timing of cardiac surgery is determined by the severity of heart failure, progression of pulmonary hypertension, and general condition, and it is generally performed within the first few months of life. Preoperative respiratory support and anti-heart failure treatment (diuretics, digoxin) are given concurrently.

Polydactyly surgery: Removal of the sixth finger is functionally advantageous when performed within the first year of life, and surgical excision followed by suturing is recommended over simple ligation. Polydactyly of the feet also requires correction for walking.

Dental treatment: Natal teeth are extracted when they are not stable because of the risk of aspiration. Orthodontic, prosthetic, and implant treatment for dental abnormalities during growth (malformed teeth, missing teeth) continues into adulthood. Regular dental follow-up is essential.

Respiratory management: Mechanical ventilatory support may be needed in cases of respiratory failure due to a narrow thorax in infancy. When pulmonary edema develops from increased pulmonary blood flow due to a congenital heart defect, diuretics and oxygen are given.

Management of other complications: Corrective osteotomy is considered when genu valgum affects walking. Regular ophthalmologic examinations evaluate visual abnormalities, and hearing tests check for complications of otitis media. When renal malformations are present, renal function follow-up is needed.


11. Prognosis

The prognosis of Ellis-van Creveld syndrome is determined mainly by the severity of congenital heart defects and the success of surgical correction. In the absence of congenital heart defects or after successful correction, life expectancy is nearly similar to that of the general population, and intellectual ability is normal.

Neonatal and infant prognosis: When congenital heart defects are present, infant mortality is high if untreated (about 30% in past reports). With advances in modern pediatric cardiac surgery, surgical success rates for single atrium and atrioventricular septal defect have greatly improved, and most patients maintain normal cardiac function after surgery. Neonatal respiratory failure due to a narrow thorax can rarely be fatal, and in such cases aggressive respiratory support is needed.

Growth and physical function: Adult height is in the range of 110~150cm, showing a wider height distribution than achondroplasia. After polydactyly surgery and genu valgum correction, walking function remains normal or nearly normal in most cases. Hand function is generally good after excision of polydactyly.

Teeth and ectoderm: Ongoing dental care for dental abnormalities is needed, and prosthetic treatment is often needed in adulthood as well. Nail abnormalities are a cosmetic problem with minimal functional impact.

Quality of life: Most patients who have undergone correction of heart defects and polydactyly surgery lead school, work, and social lives similar to the general population. Psychological adjustment and social support are important for improving quality of life. Connection with patient organizations (e.g., Little People of America) helps with psychosocial support.


12. Prevention

Primary prevention — genetic counseling and genetic testing: When affected patients or carrier families plan to have children, genetic counseling is used to discuss the recurrence risk (25%) and options for prenatal diagnosis and preimplantation genetic testing (PGT). When an EVC/EVC2 variant has been identified in the family, molecular genetic carrier testing is offered to family members. In those of Amish descent, premarital carrier screening has been reported to be effective in preventing EvC within the community.

Prenatal diagnosis: In pregnancies of carrier couples, EVC/EVC2 variants are identified by chorionic villus sampling or amniocentesis. When an affected fetus is identified, a birth plan involving pediatric cardiac surgery, pediatrics, and pediatric orthopedics teams is established before birth so that immediate cardiac evaluation and treatment can be provided in the neonatal period.

Secondary prevention — early correction of congenital heart defects: Heart defects are evaluated by echocardiography immediately after birth, and when surgery is indicated, surgical correction is performed at the appropriate time to prevent progression of heart failure and pulmonary hypertension. Early dental examination and treatment minimize oral complications.

Tertiary prevention — management of complications: Regular cardiac follow-up after cardiac surgery (echocardiography, electrocardiography); regular dental checkups; ophthalmologic examination; renal function evaluation; follow-up of spinal abnormalities; consideration of genu valgum correction. Regular comprehensive evaluations involving a multidisciplinary team allow early detection and treatment of complications.


13. References

  1. Ellis RW, van Creveld S. A syndrome characterized by ectodermal dysplasia, polydactyly, chondro-dysplasia and congenital morbus cordis: report of three cases. Arch Dis Child. 1940;15(82):65-84. DOI: 10.1136/adc.15.82.65. PMID: 21032747.

  2. McKusick VA, Egeland JA, Eldridge R, Krusen DE. Dwarfism in the Amish. I. The Ellis-van Creveld syndrome. Bull Johns Hopkins Hosp. 1964;115:306-336. PMID: 14217223.

  3. Ruiz-Perez VL, Ide SE, Strom TM, et al. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet. 2000;24(3):283-286. DOI: 10.1038/73508. PMID: 10700184.

  4. Ruiz-Perez VL, Tompson SW, Blair HJ, et al. Mutations in two nonhomologous genes in a head-to-head configuration cause Ellis-van Creveld syndrome. Am J Hum Genet. 2003;72(3):728-732. DOI: 10.1086/368063. PMID: 12571802.

  5. Galdzicka M, Patnala S, Hirshman MG, et al. A new gene, EVC2, is mutated in Ellis-van Creveld syndrome. Mol Genet Metab. 2002;77(4):291-295. DOI: 10.1016/s1096-7192(02)00178-6. PMID: 12468278.

  6. Baujat G, Le Merrer M. Ellis-van Creveld syndrome. Orphanet J Rare Dis. 2007;2:27. DOI: 10.1186/1750-1172-2-27. PMID: 17547743.

  7. Tompson SW, Ruiz-Perez VL, Blair HJ, et al. Sequencing EVC and EVC2 identifies mutations in two-thirds of Ellis-van Creveld syndrome patients. Hum Genet. 2007;120(5):663-670. DOI: 10.1007/s00439-006-0237-7. PMID: 16941203.

  8. Blair HJ, Tompson S, Liu YN, et al. Evc2 is a positive modulator of Hedgehog signalling that interacts with Evc at the cilia membrane and is also expressed in the endocardial progenitor cells. J Cell Sci. 2011;124(Pt 8):1219-1227. DOI: 10.1242/jcs.072462. PMID: 21406566.

  9. Sund KL, Roelker S, Ramachandran V, et al. Analysis of Ellis van Creveld syndrome gene products: implications for cardiovascular development and evolution. Hum Mol Genet. 2009;18(10):1813-1824. DOI: 10.1093/hmg/ddp098. PMID: 19251722.

  10. Bonafe L, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2015 revision. Am J Med Genet A. 2015;167A(12):2869-2892. DOI: 10.1002/ajmg.a.37365. PMID: 26394607.